Literature DB >> 19068004

Prevalence, correlates, and disease patterns of antipsychotic use in Taiwan.

I-Chia Chien1, Jer-Hwa Hsu, Shin-Huey Bih, Ching-Heng Lin, Yiing-Jenq Chou, Cheng-Hua Lee, Pesus Chou.   

Abstract

AIM: The population-based National Health Insurance database was used to investigate the prevalence, correlates, and disease patterns of antipsychotic use in Taiwan.
METHODS: The National Health Research Institutes provided a database of 200,000 random subjects for study. A random sample of 145 304 subjects was obtained, aged > or =18 years in 2004. Study subjects who had been given at least two antipsychotic drug prescriptions during this year were identified. The factors associated with any antipsychotic use were identified. The proportion of antipsychotic use for psychiatric and non-psychiatric disorders was also examined.
RESULTS: The 1-year prevalence of antipsychotic use was 3.5%. Antipsychotic use was found to be more prevalent by age; for women; for individuals with a lower insurance amount; for individuals with disability; and among those subjects who lived in the central or southern area. Among subjects with antipsychotic use, higher proportions of psychiatric disorders were found for schizophrenia, anxiety state, major depressive disorder, neurotic depression, dementia, and bipolar disorder. With respect to medical disorder, higher proportions of antipsychotic use were found for diseases of the digestive system; symptoms, signs, and ill-defined conditions; diseases of the respiratory system, musculoskeletal system and connective tissue, circulatory system, nervous system and sense organs, and genitourinary system.
CONCLUSIONS: Higher proportions of antipsychotic use were found for schizophrenia, depressive disorder, anxiety disorder, dementia, and bipolar disorder. More than 60% of subjects used antipsychotics for non-psychiatric disorders in Taiwan, which deserves further study for the sake of patient safety.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19068004     DOI: 10.1111/j.1440-1819.2008.01869.x

Source DB:  PubMed          Journal:  Psychiatry Clin Neurosci        ISSN: 1323-1316            Impact factor:   5.188


  5 in total

1.  Trends, correlates, and disease patterns of antipsychotic use among children and adolescents in Taiwan.

Authors:  Yuan-Chang Hsu; I-Chia Chien; Happy Kuy-Lok Tan; Ching-Heng Lin; Shu-Wen Cheng; Yiing-Jenq Chou; Pesus Chou
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2013-05-08       Impact factor: 4.328

2.  An evaluation of the effects of the novel antipsychotic drug lurasidone on glucose tolerance and insulin resistance: a comparison with olanzapine.

Authors:  Claire Wu; Jessica Yuen; Heidi N Boyda; Ric M Procyshyn; Cathy K Wang; Yahya I Asiri; Catherine C Y Pang; William G Honer; Alasdair M Barr
Journal:  PLoS One       Date:  2014-09-25       Impact factor: 3.240

Review 3.  Mini Review: Anticholinergic Activity as a Behavioral Pathology of Lewy Body Disease and Proposal of the Concept of "Anticholinergic Spectrum Disorders".

Authors:  Koji Hori; Kimiko Konishi; Misa Hosoi; Hiroi Tomioka; Masayuki Tani; Yuka Kitajima; Mitsugu Hachisu
Journal:  Parkinsons Dis       Date:  2016-09-22

4.  Use of psychoactive drugs predicts functional disability among older adults.

Authors:  Denise Mourão Falci; Juliana Vaz de Melo Mambrini; Érico Castro-Costa; Josélia Oliveira Araújo Firmo; Maria Fernanda Lima-Costa; Antônio Ignácio de Loyola Filho
Journal:  Rev Saude Publica       Date:  2019-01-31       Impact factor: 2.106

5.  Typical antipsychotics is associated with increased risk of severe exacerbation in asthma patients: a nationwide population-based cohort study.

Authors:  Chin-Wei Kuo; Szu-Chun Yang; Yu-Fen Shih; Xin-Min Liao; Sheng-Hsiang Lin
Journal:  BMC Pulm Med       Date:  2022-03-14       Impact factor: 3.317

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.